Data availability
No new data was generated.
References
Anders H-J, Saxena R, Zhao M-h, Parodis I, Salmon JE, Mohan C (2020) Lupus nephritis. Nat Rev Dis Primers. 6(1):7
Jorge A, Wallace ZS, Lu N, Zhang Y, Choi HK (2019) Renal transplantation and survival among patients with lupus nephritis: a cohort study. Ann Intern Med 170(4):240–247
Contreras G, Mattiazzi A, Guerra G et al (2010) Recurrence of lupus nephritis after kidney transplantation. J Am Soc Nephrol 21(7):1200–1207
Tanaka A, Kono H, Leung PSC, Gershwin ME (2020) Recurrence of disease following organ transplantation in autoimmune liver disease and systemic lupus erythematosus. Cell Immunol 347:104021
Lionaki S, Skalioti C, Boletis JN (2014) Kidney transplantation in patients with systemic lupus erythematosus. World J Transplant 4(3):176–182
Burgos PI, Perkins EL, Pons-Estel GJ et al (2009) Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: data from a single US institution. Arthritis Rheum 60(9):2757–2766
Dooley MA, Jayne D, Ginzler EM et al (2011) Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis. N Engl J Med 365(20):1886–1895
Tamirou F, D’Cruz D, Sangle S et al (2016) Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis. Ann Rheum Dis 75(3):526–531
Pham PT, Pham PC (2012) The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence. Nephrol Dial Transplant 27(7):2965–2971
Funding
No funding received for this work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval and informed consent
The patient consented to publishing this case report, and as per recommendations of the COPE Council Members, ethics approval of this single case study was not sought.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Disclosures: Dr. Sandal has received an education grant from Amgen Canada. Dr. Fiset has participated in paid consulting services or has received honoraria for participating in advisory boards with Amgen, Astellas, AstraZeneca, Bristol Meyers Squibb, EMD Serono, Incyte, Merck, Novartis, Pfizer, and Precision Rx-Dx. Dr. Samanta participated in advisory boards for Novartis, GSK, Otsuka, and receives honoraria from Alexion and AstraZeneca. The rest of the authors have no relevant disclosure.
Rights and permissions
About this article
Cite this article
Robert, JT., Rajaram, A., Fiset, P.O. et al. Class V lupus nephritis recurrence with histologic resolution in a kidney transplant recipient on a pregnancy-adapted immunosuppression protocol: a lesson for the clinical nephrologist. J Nephrol (2024). https://doi.org/10.1007/s40620-024-01920-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s40620-024-01920-z